e-learning
resources
Virtual 2020
Monday, 07.09.2020
Lung cancer screening: are we back to the individualised decision-making process?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sublobar resections vs lobectomy for early stage lung cancer: where do we stand?
R. Petersen (Copenhagen, Denmark)
Source:
Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Session:
Lung cancer screening: are we back to the individualised decision-making process?
Session type:
Symposium
Number:
3863
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Petersen (Copenhagen, Denmark). Sublobar resections vs lobectomy for early stage lung cancer: where do we stand?. Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Anatomic segmentectomy vs. lobectomy for early stage lung cancer
Source: International Congress 2014 – Current therapeutic options in stage I non-small cell lung cancer (NSCLC)
Year: 2014
Surgical management of early lung cancer: the surgeon's view
Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated?
Year: 2005
Sublobar resection versus lobectomy in non-small cell lung cancer: a propensity matched analysis
Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Year: 2020
Sublobar resection for lung cancer
Source: Eur Respir J 2009; 33: 426-435
Year: 2009
Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
VATS in lung cancer treatment: for which patients?
Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases
Year: 2014
Outcomes of sublobar and lobar resection for stage 1 non-small cell lung cancer.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Treatment of early (stage I/II) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
The surgical treatment of lung cancer
Source: Eur Respir Mon; 2009: 44: 187–206
Year: 2009
A case-matched study of VATS lobectomy versus open segmentectomy for stage I NSCLC in COPD
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Resection for metachronous lung cancer after pneumonectomy
Source: Eur Respir J 2005; 26: Suppl. 49, 309s
Year: 2005
Bronchopleural fistula-risk factors and treatment after lung cancer surgery
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007
Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021
Follow-up after lung cancer resection: is intensified also justified?
Source: Eur Respir J 2013; 42: 1178-1179
Year: 2013
Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis
Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Year: 2020
VATS wedge pulmonary resections for diffuse lung disease: stappler versus non-stappler resections
Source: Eur Respir J 2004; 24: Suppl. 48, 172s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept